Co-Diagnostics, Inc. Announces Second Quarter 2025 Earnings Release Date and Webcast
Co-Diagnostics (NASDAQ:CODX), a molecular diagnostics company, has scheduled its second quarter 2025 earnings release for Thursday, August 14, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET the same day.
Key executives participating in the call include CEO Dwight Egan, CFO Brian Brown, and Head of IR Andrew Benson. Investors can access the webcast through the company's IR website and join the conference call via toll-free (888-880-3330) or toll (646-357-8766) numbers. A recording will be available on the company's website for those unable to attend.
Co-Diagnostics (NASDAQ:CODX), un'azienda di diagnostica molecolare, ha programmato la pubblicazione dei risultati del secondo trimestre 2025 per gioved矛 14 agosto 2025, dopo la chiusura del mercato. La societ脿 terr脿 una conference call e una webcast alle 16:30 ET dello stesso giorno.
I principali dirigenti che parteciperanno alla chiamata includono il CEO Dwight Egan, il CFO Brian Brown e il responsabile delle relazioni con gli investitori Andrew Benson. Gli investitori potranno accedere alla webcast tramite il sito IR dell'azienda e partecipare alla conference call chiamando i numeri gratuiti (888-880-3330) o a pagamento (646-357-8766). Una registrazione sar脿 disponibile sul sito web della societ脿 per chi non potr脿 partecipare.
Co-Diagnostics (NASDAQ:CODX), una empresa de diagn贸stico molecular, ha programado la publicaci贸n de sus resultados del segundo trimestre de 2025 para el jueves 14 de agosto de 2025, tras el cierre del mercado. La compa帽铆a realizar谩 una llamada conferencia y una transmisi贸n web a las 4:30 p.m. ET del mismo d铆a.
Los principales ejecutivos que participar谩n en la llamada incluyen al CEO Dwight Egan, al CFO Brian Brown y al jefe de relaciones con inversores Andrew Benson. Los inversores podr谩n acceder a la transmisi贸n web a trav茅s del sitio web de relaciones con inversores de la empresa y unirse a la llamada conferencia mediante n煤meros gratuitos (888-880-3330) o de pago (646-357-8766). Una grabaci贸n estar谩 disponible en el sitio web de la compa帽铆a para quienes no puedan asistir.
Co-Diagnostics (NASDAQ:CODX)電� 攵勳瀽 歆勲嫧 須岇偓搿滌劀 2025雲� 8鞗� 14鞚� 氇╈殧鞚�, 鞛� 毵堦皭 頉� 2025雲� 2攵勱赴 鞁れ爜 氚滍憸毳� 鞓堨爼頃橁碃 鞛堨姷雼堧嫟. 臧欖潃 雮� 霃欕秬 響滌鞁� 鞓ろ泟 4鞁� 30攵�鞐� 旎嵓霟办姢 旖� 氚� 鞗轨簮鞀ろ姼毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
鞚措矆 旖滌棎電� CEO 霌滌檧鞚错姼 鞚搓贝, CFO 敫岆澕鞚挫柛 敫岆澕鞖�, IR 毂呾瀯鞛� 鞎る摐毳� 氩れ姩鞚� 彀胳棳頃╇媹雼�. 韴瀽鞛愲摛鞚� 須岇偓 IR 鞗轨偓鞚错姼毳� 韱淀暣 鞗轨簮鞀ろ姼鞐� 鞝戩啀頃� 靾� 鞛堨溂氅�, 氍措 鞝勴檾(888-880-3330) 霕愲姅 鞙犽 鞝勴檾(646-357-8766)毳� 韱淀暣 旎嵓霟办姢 旖滌棎 彀胳棳頃� 靾� 鞛堨姷雼堧嫟. 彀胳劃頃橃 氇豁晿電� 攵勲摛鞚� 鞙勴暣 雲轨潓氤胳澊 須岇偓 鞗轨偓鞚错姼鞐� 鞝滉车霅� 鞓堨爼鞛呺媹雼�.
Co-Diagnostics (NASDAQ:CODX), une soci茅t茅 de diagnostic mol茅culaire, a programm茅 la publication des r茅sultats du deuxi猫me trimestre 2025 pour le jeudi 14 ao没t 2025, apr猫s la cl么ture du march茅. La soci茅t茅 organisera une conf茅rence t茅l茅phonique et une webdiffusion 脿 16h30 ET le m锚me jour.
Les principaux dirigeants participant 脿 l'appel sont le PDG Dwight Egan, le directeur financier Brian Brown et le responsable des relations investisseurs Andrew Benson. Les investisseurs peuvent acc茅der 脿 la webdiffusion via le site IR de la soci茅t茅 et rejoindre la conf茅rence t茅l茅phonique via des num茅ros gratuits (888-880-3330) ou payants (646-357-8766). Un enregistrement sera disponible sur le site de la soci茅t茅 pour ceux qui ne pourront pas assister.
Co-Diagnostics (NASDAQ:CODX), ein Unternehmen f眉r molekulare Diagnostik, hat die Ver枚ffentlichung der Ergebnisse f眉r das zweite Quartal 2025 f眉r Donnerstag, den 14. August 2025 nach B枚rsenschluss geplant. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und ein Webcast veranstalten.
Wichtige F眉hrungskr盲fte, die an dem Anruf teilnehmen, sind CEO Dwight Egan, CFO Brian Brown und der Leiter der Investor Relations Andrew Benson. Investoren k枚nnen 眉ber die IR-Website des Unternehmens auf das Webcast zugreifen und der Telefonkonferenz 眉ber geb眉hrenfreie (888-880-3330) oder geb眉hrenpflichtige (646-357-8766) Nummern beitreten. Eine Aufzeichnung wird auf der Unternehmenswebsite f眉r diejenigen verf眉gbar sein, die nicht teilnehmen k枚nnen.
- None.
- None.
The conference call and webcast will be available via:
Webcast: on the page, or accessible directly
Conference Call: 888-880-3330聽(Toll Free) or (646) 357-8766 (Toll)
If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a
View original content to download multimedia:
SOURCE Co-Diagnostics
FAQ
When will Co-Diagnostics (CODX) release Q2 2025 earnings?
How can investors access Co-Diagnostics Q2 2025 earnings call?
Who will participate in Co-Diagnostics Q2 2025 earnings call?
Will Co-Diagnostics Q2 2025 earnings call be recorded?
